Femasys (FEMY) Shares Outstanding (2020 - 2026)
Femasys (FEMY) posted Shares Outstanding (Entity) of $4.6 million for Q1 2026, up 132.94% on a QoQ basis from $2.0 million in Q4 2025, and up 238.63% year-over-year from $1.4 million in Q1 2025.
Femasys (FEMY) Shares Outstanding (2020 - 2026) Analysis & Trends
Femasys' Shares Outstanding (Entity) history runs 6 years deep, the most recent figure standing at $4.6 million for Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 238.63% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (up 238.63% YoY) and the FY2025 annual result came in at $2.0 million, up 68.49% from the prior year.
- Shares Outstanding (Entity) was $4.6 million for Q1 2026 at Femasys, up from $2.0 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $4.6 million in Q1 2026 and bottomed at $596069.0 in Q1 2022.
- A 5-year average of $1.3 million and a median of $1.1 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Peak annual rise in Shares Outstanding (Entity) reached 474.56% in 2022, while the deepest fall reached 0.12% in 2022.
- Femasys' Shares Outstanding (Entity) stood at $599346.0 in 2022, then climbed by 28.34% to $769219.0 in 2023, then soared by 52.58% to $1.2 million in 2024, then soared by 68.49% to $2.0 million in 2025, then jumped by 132.94% to $4.6 million in 2026.
- Business Quant data shows FEMY's Shares Outstanding (Entity) at $4.6 million in Q1 2026, $2.0 million in Q4 2025, and $2.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 33,163,703.85 Bn | 33,163,702.19 Bn | 1.53 Bn | 487,200.00 Bn |
| 2 | Intuitive Surgical | 119.67 Bn | 114.45 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Becton Dickinson | 43.92 Bn | 43.11 Bn | 2.15 Bn | 280.64 Mn |
| 4 | Medline | 31.71 Bn | 29.47 Bn | 1.84 Bn | 819.08 Mn |
| 5 | Resmed | 28.46 Bn | 26.80 Bn | 890.98 Mn | 145.34 Mn |
| 6 | West Pharmaceutical Services | 23.80 Bn | 23.28 Bn | 296.40 Mn | 72.00 Mn |
| 7 | Cooper Companies | 13.77 Bn | 13.63 Bn | 735.40 Mn | 195.00 Mn |
| 8 | Solventum | 13.63 Bn | 13.06 Bn | 1.10 Bn | 174.20 Mn |
| 9 | Align Technology | 11.94 Bn | 10.88 Bn | 736.59 Mn | 71.43 Mn |
| 10 | Femasys | 17.09 Mn | 11.70 Mn | - | 4.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.61 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.11 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 1.11 Mn |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 769,219.00 |
| Sep 30, 2023 | 754,657.00 |
| Jun 30, 2023 | 655,380.00 |
| Mar 31, 2023 | 593,613.00 |
| Dec 31, 2022 | 590,751.00 |
| Sep 30, 2022 | 590,680.00 |
| Jun 30, 2022 | 590,649.00 |
| Mar 31, 2022 | 590,208.00 |
| Dec 31, 2021 | 335,601.00 |
| Sep 30, 2021 | 589,986.00 |
| Jun 30, 2021 | 103,826.00 |